bradykinin, leu(8)-des-arg(9)- has been researched along with endothelin-1 in 1 studies
Studies (bradykinin, leu(8)-des-arg(9)-) | Trials (bradykinin, leu(8)-des-arg(9)-) | Recent Studies (post-2010) (bradykinin, leu(8)-des-arg(9)-) | Studies (endothelin-1) | Trials (endothelin-1) | Recent Studies (post-2010) (endothelin-1) |
---|---|---|---|---|---|
102 | 0 | 7 | 12,740 | 632 | 3,394 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akira, A; Andoh, T; Kuraishi, Y; Saiki, I | 1 |
1 other study(ies) available for bradykinin, leu(8)-des-arg(9)- and endothelin-1
Article | Year |
---|---|
Bradykinin increases the secretion and expression of endothelin-1 through kinin B2 receptors in melanoma cells.
Topics: Animals; Bradykinin; Bradykinin B1 Receptor Antagonists; Bradykinin B2 Receptor Antagonists; Cell Line, Tumor; Endothelin-1; Gene Expression; Gene Expression Regulation, Neoplastic; Melanoma, Experimental; Mice; Receptor, Bradykinin B1; Receptor, Bradykinin B2 | 2010 |